secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-06-12T12:00:17+00:00
Accession:  0001437749-26-020384
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia regains Nasdaq minimum equity compliance after $4.9M ATM raise
------------------------------------------------------------------------

- Nasdaq extended compliance deadline to Oct 7, 2026 after company submitted plan to regain minimum $2.5M equity.
- Raised ~$4.9M net through ATM sale of 4.0M shares at avg $1.27 from Apr 1 to Jun 5, 2026.
- Company believes stockholders' equity now exceeds $2.5M, meeting Nasdaq continued listing requirement.
- Nasdaq will monitor compliance; delisting risk remains if not sustained at next periodic report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926020384/0001437749-26-020384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926020384/bcda20260612_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-020384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer